|
|
|
Updated 8/20/08 |
|
Recently Posted: Atypical Antipsychotics Report
DERP Reports and Key Questions
|
HRC Report
|
Executive Summary
|
Angiotensin II Receptor Antagonists or AIIRA |
|
|
Antidepressants |
|
|
Antiemetics or NAE |
|
|
Antiepileptic or AP |
|
|
Attention Deficit Hyperactivity Disorder or ADHD |
|
|
Atypical Antipsychotics |
|
|
Autism or ASD |
|
|
Beta 2 Agonists or B2 |
|
|
Beta Blocker or BB |
|
|
Calcium Channel Blockers or CCB |
|
|
Combination Products for Type 2 DM & Hyperlipidemia or FDCP |
|
|
Hormone Replacement Therapy - HRT |
|
|
Inhaled Corticosteroid or ICS |
|
|
Insomnia |
|
|
Long-acting Analgesics for Non-cancer Pain or OPIOID |
|
|
Multiple Sclerosis or MS
|
|
|
Newer Antiplatelet or AP |
|
|
Neuropathic Pain |
|
|
Non-steroidal Anti-inflammatory Drugs or NSAIDS |
|
|
Obesity, Surgical |
|
|
Obesity, Medical |
|
|
Oral Hypoglycemics or OH |
|
|
Over Active Bladder or OAB |
|
|
Peginterferons for Hepatitis C |
|
|
Proton Pump Inhibitor or PPI |
|
|
Skeletal Muscle Relaxers or SMR |
|
|
STATIN |
|
|
Targeted Immune Modulators or TIM |
|
|
Thiazolidinediones or TZD |
|
|
TRIPTAN |
|
|
|
|
|
|